top of page

BackTable / VI / Podcast / Episode #200

PAD Stenting Algorithm

with Dr. Luke Wilkins

We talk with Dr. Luke Wilkins about his stenting algorithm for treating peripheral artery disease, including a step by step discussion of the decision tree when deciding whether or not to stent.

Sponsored by:

Boston Scientific Eluvia Drug-Eluting Stent

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

PAD Stenting Algorithm with Dr. Luke Wilkins on the BackTable VI Podcast)
Ep 200 PAD Stenting Algorithm with Dr. Luke Wilkins
00:00 / 01:04

BackTable, LLC (Producer). (2022, April 14). Ep. 200 – PAD Stenting Algorithm [Audio podcast]. Retrieved from

Dr. Luke Wilkin's PAD Stenting Algorithm

Dr. Luke Wilkin's PAD stenting algorithm

Image provided by Dr. Luke Wilkins.

BackTable CMEfy button

Stay Up To Date



Sign Up:

Podcast Contributors

Dr. Luke Wilkins discusses PAD Stenting Algorithm on the BackTable 200 Podcast

Dr. Luke Wilkins

Dr. Luke Wilkins is a practicing interventional radiologist at University of Virginia VIR.

Dr. Aparna Baheti discusses PAD Stenting Algorithm on the BackTable 200 Podcast

Dr. Aparna Baheti

Dr. Aparna Baheti is a practicing Interventional Radiologist in Tacoma, Washington.


In this episode, our host Dr. Aparna Baheti interviews interventional radiologist Dr. Luke Wilkins about his treatment algorithm for Peripheral Arterial Disease (PAD). This algorithm is linked below, under “Resources.”

Dr. Wilkins starts by explaining his treatment decisions for non-occlusive lesions. If the lesion is less than 10 cm he prefers to use directional atherectomy and percutaneous transluminal angioplasty (PTA). However, if the lesion is greater than 10 cm, directional atherectomy poses the risk of distal embolization, so he will only perform PTA. In both cases, he recommends using IVUS to evaluate the efficacy of the treatment and then proceeding with a drug-coated balloon (DCB) to prevent re-stenosis.

On the other hand, if the disease is occlusive, Dr. Wilkins first attempts to cross the lesion. This can be achieved by going through microchannels with a guidewire or boring through the occlusion with a crossing device. If the lesion is unable to be crossed, he attempts subintimal recanalization. We discuss spontaneous re-entry into the true lumen, as well as re-entry devices like the Outback and the Pioneer catheters. We also take a detour into the Subintimal Arterial Flossing with Anterograde-Retrograde Intervention (SAFARI) technique that can be used if re-entry is challenging. After crossing is complete, Dr. Wilkins evaluates vessel diameter. In his experience, vessels that are wider than 5 mm have better stent patency, so he will place a drug eluting stent. In vessels of smaller diameters, Dr. Wilkins relies on other approaches such as interwoven stents with smaller diameters, directional atherectomy, and Tacks (to treat dissection flaps).

Finally, Dr. Wilkins discusses medical management and follow-up care for PAD patients. He recommends dual antiplatelet therapy, smoking cessation, and if claudication was an initial concern, patient education on the importance of walking. He follows up with patients in 1, 6, and 9 months, and then annually. During each follow up appointment, he checks ABI, PVR, and arterial duplex for clinical improvement.


PAD Stenting Algorithm Decision Tree:

TASC Guidelines:

Articles Mentioned:
Schneider PA, Laird JR, Doros G, Gao Q, Ansel G, Brodmann M, Micari A, Shishehbor MH, Tepe G, Zeller T. Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon. Journal of the American College of Cardiology. 2019 May 28;73(20):2550-63.

Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW. Association of survival with femoropopliteal artery revascularization with drug-coated devices. JAMA cardiology. 2019 Apr 1;4(4):332-40.

Freisinger E, Koeppe J, Gerss J, Goerlich D, Malyar NM, Marschall U, Faldum A, Reinecke H. Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis. European heart journal. 2020 Oct 7;41(38):3732-9.

Disclaimer: The Materials available on are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Become a BackTable Sponsor

Up Next

Transitioning from Academia to Private OBL Practice with Dr. Jafar Golzarian on the BackTable VI Podcast)
The 'Woundosome' Concept with Dr. Lorenzo Patrone on the BackTable VI Podcast)
Percutaneous Transmural Arterial Bypass: Updates on Technique & Data with Dr. Peter Soukas on the BackTable VI Podcast)
Below the Ankle Expertise: Distal Pedal Access with Dr. Marta Lobato on the BackTable VI Podcast)
The Multidisciplinary Approach to Combatting CLI Globally with Dr. Jos van den Berg on the BackTable VI Podcast)
Iliofemoral Stenting: Decision-Making & Best Practices Explored with Dr. Kush Desai and Dr. Steven Abramowitz on the BackTable VI Podcast)



Arterial Stenting Procedure Prep
Atherectomy Procedure Prep
Critical Limb Ischemia (CLI) Condition Overview

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page